Personal tools
Log in

Skip to content. | Skip to navigation

Sections
Document Actions
enGINe Newsletter

Subscribe here to the enGINe Newsletter.

Search
Documents in the library
Positronen-Emissions-Tomograph...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Positronen-Emissions-Tomographie (PET) bei Ovarialkarzinom

Status:
Published
Date of publication:
Mar 27, 2012
Belimumab - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Belimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Fampridin - Nutzenbewertung ge...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Fampridin - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 26, 2012
Ipilimumab - Nutzenbewertung g...

IQWiG (DE) - Institute for Quality and Efficiency in Health Care

Ipilimumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

Status:
Published
Date of publication:
Apr 27, 2012
Evidence-based care guideline ...

AHRQ (US) - Agency for Healthcare Research and Quality

Evidence-based care guideline for prevention and management of acute gastroenteritis (AGE) in children aged 2 months to 18 years. Cincinnati Children's Hospital Medical Center. NGC:008846

Status:
Published
Date of publication:
Dec 21, 2011
More guidelines
 

Raiders of the lost article

 

Chapter Nine - End Game

The guideline on “Appropriate and cost effect use of the elixir of life”, by Gray, D’Ay (International Man of Guidelines), Ana Lysis (Fine Figure of a Girl) and Lance Ett (Impact Factor off the Page), will be published on 1st April 2010 and will be available from all good bookshops.

Implementation of this guideline is a local issue but the guideline will be accompanied by a set educational of slides for free download, which is the best we can do.

The guideline will be reviewed in three years time if we can find the money. There’s no money for an audit so don’t even ask.

The guideline on “Appropriate and cost effect use of the elixir of life” is being published as a tribute to Gray, D’Ay (International Man of Guidelines) who unfortunately died during its development. Gray was crushed beneath a 3m pile of Cochrane reviews that toppled from their precarious perch on a GP’s desk.

The end!!

Page last updated: Jul 28, 2010

Bookmark & Share:

  • Facebook
  • Google Bookmarks
  • Twitter

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.